Myeloma UK – current focus and future directions
Generics for chronic myeloid leukemia treatment – a hot topic at ASH 2016 as imatinib patent expires
The importance of multiple myeloma foundations and a patient story
Paul Richardson et al.
Working with smaller research companies
Stéphane de Botton
New European programs and initiatives in hematology